• Civica to Build an Essential Medicines Manufacturing Facility in Virginia contractpharma
    January 26, 2021
    ​Civica Rx has unveiled plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, VA, potentially creating more than 180 jobs. The new plant represents a $124.5 million investment.
  • Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area prnasia
    January 21, 2021
    Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony ...
  • Fujifilm to Invest $40M in New Facility contractpharma
    January 06, 2021
    Fujifilm Corporation has announced an investment of approximately $40 million in Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, to establish a new ...
  • Oncorus to Build GMP Viral Immunotherapy Mfg. Facility contractpharma
    January 05, 2021
    Oncorus, Inc., a clinical stage biopharmaceutical company developing next-gen viral immunotherapies for cancer, has signed a 15-year lease to build a state-of-the-art, 88,000 sq.-ft. GMP viral immunotherapy clinical manufacturing facility in Andover ...
  • Wallace Pharma sets up R&D Centre in Goa expresspharma
    January 04, 2021
    Mumbai-based Wallace Pharma has set up a research and development (R&D) centre ‘Wallace Innovation Centre’ in Ponda, Goa.
  • Lonza Expands Conjugation Facility in Visp contractpharma
    December 22, 2020
    Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.
  • Thermo Fisher Expands Plasmid DNA Mfg. Capabilities contractpharma
    December 18, 2020
    New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.
  • Aurinia and Lonza Expand Manufacturing Partnership contractpharma
    December 17, 2020
    ​Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp ...
  • Catalent Appoints Minakuchi Facility GM contractpharma
    December 11, 2020
    ​Catalent has appointed Nakaya “Nick” Matsumaru as general manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
  • Piramal Pharma Solutions invests ~$32 mn in its Riverview Michigan facility expresspharma
    December 10, 2020
    Piramal Pharma’s Pharma Solutions business announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharma ingredients (APIs).
PharmaSources Customer Service